Stock News

Voyager Therapeutics, Inc. (VYGR) Reaches $14.68 After 5.00% Up Move; Cannell Peter B & Company Has Trimmed By $673,440 Its Brookfield Infrastructure Partners (BIP) Position

The stock of Voyager Therapeutics, Inc. (NASDAQ:VYGR) is a huge mover today! The stock increased 5.54% or $0.77 during the last trading session, reaching $14.68. About 232,929 shares traded. Voyager Therapeutics, Inc. (NASDAQ:VYGR) has declined 18.89% since November 30, 2016 and is downtrending. It has underperformed by 35.59% the S&P500.The move comes after 9 months positive chart setup for the $461.68M company. It was reported on Nov, 30 by Barchart.com. We have $15.41 PT which if reached, will make NASDAQ:VYGR worth $23.08 million more.

Cannell Peter B & Company Inc decreased Brookfield Infrastructure Partners (BIP) stake by 8.96% reported in 2017Q2 SEC filing. Cannell Peter B & Company Inc sold 16,836 shares as Brookfield Infrastructure Partners (BIP)’s stock rose 9.21%. The Cannell Peter B & Company Inc holds 171,006 shares with $7.00M value, down from 187,842 last quarter. Brookfield Infrastructure Partners now has $17.89B valuation. The stock decreased 0.17% or $0.07 during the last trading session, reaching $43.7. About 155,720 shares traded. Brookfield Infrastructure Partners L.P. (NYSE:BIP) has risen 38.95% since November 30, 2016 and is uptrending. It has outperformed by 22.25% the S&P500.

Among 9 analysts covering Brookfield Infrastructure Partners (NYSE:BIP), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Brookfield Infrastructure Partners had 33 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, November 5 report. TD Securities maintained the stock with “Buy” rating in Monday, September 26 report. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) has “Outperform” rating given on Friday, June 16 by Credit Suisse. Scotia Capital maintained Brookfield Infrastructure Partners L.P. (NYSE:BIP) rating on Tuesday, August 18. Scotia Capital has “Sector Perform” rating and $50 target. The rating was maintained by RBC Capital Markets with “Buy” on Friday, August 4. BMO Capital Markets maintained the shares of BIP in report on Wednesday, November 1 with “Buy” rating. The company was maintained on Monday, September 19 by Citigroup. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) has “Buy” rating given on Friday, June 9 by RBC Capital Markets. As per Wednesday, January 13, the company rating was upgraded by Raymond James. The company was downgraded on Monday, September 26 by Raymond James.

Cannell Peter B & Company Inc increased Wen Hldg Inc stake by 660,160 shares to 1.44M valued at $46.77M in 2017Q2. It also upped Coca Cola Co (NYSE:KO) stake by 8,875 shares and now owns 319,276 shares. Fidelity National Financial (NYSE:FNF) was raised too.

Analysts await Brookfield Infrastructure Partners L.P. (NYSE:BIP) to report earnings on February, 7. They expect $0.82 earnings per share, up 18.84% or $0.13 from last year’s $0.69 per share. BIP’s profit will be $335.64M for 13.32 P/E if the $0.82 EPS becomes a reality. After $0.81 actual earnings per share reported by Brookfield Infrastructure Partners L.P. for the previous quarter, Wall Street now forecasts 1.23% EPS growth.

Among 6 analysts covering Voyager Therapeutics (NASDAQ:VYGR), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Voyager Therapeutics had 7 analyst reports since December 7, 2015 according to SRatingsIntel. The rating was initiated by Wells Fargo on Friday, May 20 with “Outperform”. The rating was initiated by Chardan Capital Markets with “Sell” on Wednesday, December 9. As per Monday, December 7, the company rating was initiated by Piper Jaffray. The firm earned “Neutral” rating on Monday, January 25 by Chardan Capital Markets. Cowen & Co initiated the stock with “Outperform” rating in Monday, December 7 report. The rating was initiated by Stifel Nicolaus with “Buy” on Friday, July 15. The rating was initiated by Wedbush with “Outperform” on Monday, December 7.

Analysts await Voyager Therapeutics, Inc. (NASDAQ:VYGR) to report earnings on March, 21. They expect $-0.76 earnings per share, down 33.33% or $0.19 from last year’s $-0.57 per share. After $-0.89 actual earnings per share reported by Voyager Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -14.61% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *